AorTech BioMaterials
  • HOME
  • OUR BUSINESS
    • ABOUT AORTECH
    • VISION FOR GROWTH
    • BIOMEDICAL POLYMERS
    • COMPONENT SUPPLY
    • DEVICE DEVELOPMENT
    • NEWS
  • OUR POLYMER TECHNOLOGY
    • ELAST EON
    • ECSIL
    • E-RIM
    • NEW FEATURE TECHNOLOGY
    • TECHNICAL LIBRARY
    • PATENTS
  • OUR CAPABILITIES
    • OUR FACILITIES
    • QUALITY
    • APPLICATIONS DEVELOPMENT
    • RESEARCH & DEVELOPMENT
  • INVESTOR RELATIONS
    • DIRECTORS
    • CORPORATE GOVERNANCE
    • COMPANY REPORTS
    • RNS ANNOUNCEMENTS
  • FAQ
  • CONTACT US
  • Directors
  • Corporate Governance
  • Company Reports
  • RNS Announcements

AorTech's Directors

AorTech International is listed on the UK Aim market (AIM: AOR) and has operations in the US and Australia.  The AorTech Group is focused on the commercialization of Elast-Eon polymers, components and medical devices.

Jon Pither, Chairman, non-Executive Director (appointed Chairman 12 May 2005)
Frank Maguire, Chief Executive Officer (appointed April 2003)
Eddie McDaid, non-Executive Director (appointed 14 November 2005)
Dr. Stuart Rollason, non-Executive Director (appointed 13 May 2005)
Gordon Wright, non-Executive Director (appointed 14 November 2005)
Contact Details  |  Terms of Use  |  Privacy Policy  |  Copyright AorTech 2010